Overview
Federal Regulations
All
Driver
Vehicle
Company
FMCSA Hazmat
Regulatory Guidance
Rulemakings and Notices
Final Rules
Interim Final Rules
Proposed Rules
Notices
Topics of Interest
Hours-of-Service (HOS) Summary
Distracted Driving
Hazardous Materials
Intermodal Equipment Providers (IEP)
New Entrant Safety Assurance
Medical Program
Medical Expert Panels
NAFTA Rules
Drug & Alcohol Testing
 
  
 

Final Rule: Harmonizing Schedule I Drug Requirements

NOTE: The item below may be impacted by a more recently published rulemaking or notice. View Related Rulemakings for more information.

Federal Register: 77FR 4479
RIN: 2126-AB35
Docket #: FMCSA-2011-0073
(What is this?)
49 CFR Part: 382, 391
 
Publication Date: 1/30/2012
Effective Date: 2/29/2012

Action:

Final Rule

Summary:

The Federal Motor Carrier Safety Administration (FMCSA) amends the physical qualifications for drivers and the instructions for the medical examination report to clarify that drivers may not use Schedule I drugs and be qualified to drive commercial motor vehicles (CMVs) under any circumstances. The rule harmonizes FMCSA's provisions regarding preemployment and return-to-duty test refusals with corresponding Department of Transportation (DOT)-wide provisions. Finally, the rule corrects inaccurate uses of the term "actual knowledge."
[View Full Text] [View PDF Version]

Related Rulemakings


RINPublished Title Category
2126-AB35 02/22/2012 Harmonizing Schedule I Drug Requirements Final rule; correction.
2126-AB35 07/08/2011 Harmonizing Schedule I Drug Requirements Notice of proposed rulemaking.



- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
         
Examples: RIN 2126-AA78, Exemption


 
 
Connect with us
FMCSA's Contact Us  FMCSA's Facebook page

Feedback | Privacy Policy | USA.gov | Freedom of Information Act (FOIA) | Accessibility | OIG Hotline | Web Policies and Important Links | Site Map | Plug-ins

Federal Motor Carrier Safety Administration
1200 New Jersey Avenue SE, Washington, DC 20590 • 1-800-832-5660 • TTY: 1-800-877-8339 • Field Office Contacts